All In Biotech

Free tool

FAERS Monitor: Tudorza Pressair

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 202450 or its brand name (Tudorza Pressair, Aclidinium Bromide). Reports on generic versions are filed under their own applications.

Reports

6,392

Serious

3,559

56% of reports

Hospitalization

1,901

Death reported

290

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea1,875
  • device malfunction1,282
  • drug dose omission1,017
  • asthma819
  • chronic obstructive pulmonary disease784
  • intentional product misuse741
  • off label use720
  • pneumonia718
  • wheezing666
  • cough658
  • product quality issue592
  • device issue475
  • obstructive airways disorder450
  • drug ineffective413
  • malaise392

Reports by year received

View as table
YearReports
20092
20105
20116
201212
2013221
2014339
2015631
2016862
2017912
2018875
2019472
2020385
2021421
2022402
2023329
2024262
2025175
202681

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,767 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
obstructive airways disorderSignal450138.7126.658,938
device malfunctionSignal1,28261.158.274,629
chronic obstructive pulmonary diseaseSignal78450.247.037,264
wheezingSignal66637.434.823,335
intentional product misuseSignal74128.126.219,241
asthmaSignal81924.022.518,006
drug dose omissionSignal1,01720.419.218,738
device issueSignal47517.516.17,373
product quality issueSignal59214.413.37,385
dyspnoeaSignal1,87510.910.517,319
coughSignal6587.77.23,896
pneumoniaSignal7187.36.83,958
malaiseSignal3922.92.7511
off label useSignal7202.72.5806
drug ineffective4131.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.